Quantcast
Home > Quotes > PLSE

Pulse Biosciences, Inc Common Stock (DE) (PLSE) Quote & Summary Data

PLSE 
$12.46
*  
0.07
0.56%
Get PLSE Alerts
*Delayed - data as of Jul. 22, 2019  -  Find a broker to begin trading PLSE now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    PLSE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
27
Today's High / Low
$ 12.52 / $ 12.21
Share Volume
13,953
50 Day Avg. Daily Volume
38,991
Previous Close
$ 12.39
52 Week High / Low
$ 19.77 / $ 8.60
Market Cap
258,051,659
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.62

Intraday Chart

Shares Traded

Share Volume:
13,953
50 Day Avg. Daily Volume:
38,991

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.18

Trading Range

The current last sale of $12.46 is 44.88% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 12.52 $ 19.77
 Low: $ 12.21 $ 8.60

Company Description (as filed with the SEC)

In this Annual Report on Form 10-K, references to "Pulse," "Pulse Biosciences," "we," "us," "our" and the "Company" refer to Pulse Biosciences, Inc. and its wholly owned subsidiaries, unless expressly indicated or the context otherwise requires. Pulse Biosciences, Pulse TX, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries. Overview Pulse Biosciences, Inc. is a clinical stage medical therapy company pursuing commercial introduction of our proprietary CellFX(TM) System utilizing our patent-protected Nano-Pulse Stimulation(TM) (NPS(TM)) platform technology. With our proprietary CellFX System, we can deliver a unique cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage.  ... More ...  



Risk Grade

Where does PLSE fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 12.46
Open Date:
Jul. 22, 2019
Close Price:
$ 12.46
Close Date:
Jul. 22, 2019


Consensus Recommendation

Analyst Info